Pain. Acute pain, not elsewhere classified
Conditions
Interventions
Intervention 1: Intervention group: Patients coming to the ER with pain level greater than 7 out of 10 who get treated by 1.5 mg per kg nebulized ketamine. Intervention 2: Control group: Patients com
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Acute pain in patients referred to the ER with a Visual analog scale (VAS) equivalent to or greater than 7 out of 10
Exclusion criteria
Exclusion criteria: Having a mental illness mentioned by the patient Head trauma Ischemic heart disease Acute heart failure Respiratory distress Systolic blood pressure greater than 180 mmHg or less than 90 mmHg Asthma High intracranial pressure Pregnancy Addiction Inability to describe the pain Using other analgesics before admission History of being allergic to Ketamine or Morphine or any contraindication of using these drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain level. Timepoint: Before intervention and in 5, 10, 20, 40, 60 minutes after intervetion. Method of measurement: Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: 60 minutes after receiving an intervention. Method of measurement: A questionnaire that includes possible side effects after receiving the drugs. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSahar Gholamzadeh
Ahvaz University of Medical Sciences
Outcome results
None listed